Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Granuloma

• Janus Kinase Inhibition in Granuloma Annulare
• Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare
• Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial
• Corticosteroid Intra-lesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone, A Randomized-Controlled Pilot Study.
• Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
• A Pilot Study of Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
• A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
• Double Ligation and Topical Silver Nitrate
• IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
• Vitamin D3 For CGD Patients With BCGosis/Itis
• Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare
• Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
• Pain Outcomes Following Intralesional Corticosteroid Injections
• Denosumab in Subjects With Giant Cell Rich Tumors of Bone
• Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
• Pioglitazone Therapy for Chronic Granulomatous Disease
• Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
• High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
• Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
• Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma
• Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
• Treatment of Tracheostomy Granulomas
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
• Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
• Treatment of Granuloma Umbilical in Newborn Babies
• Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
• Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease
• Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
• Gene Therapy for Chronic Granulomatous Disease in Korea
• Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
• Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas
• Gene Therapy for Chronic Granulomatous Disease
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
• Gene Therapy for Chronic Granulomatous Disease
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
• Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
• Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
• Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
• A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood
• Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease